BACKGROUND AND OBJECTIVES: Patients with decompensated cirrhosis rarely receive palliative and supportive care interventions, which are routine in other life-limiting diseases. We aimed to design and evaluate a prognostic screening tool to routinely identify inpatients with decompensated cirrhosis at high risk of dying over the coming year, alongside the development of a supportive care intervention. DESIGN: Clinical notes from consecutive patients admitted as an emergency to University Hospitals Bristol with a diagnosis of cirrhosis over two distinct 90-day periods were scrutinised retrospectively for the presence or absence of five evidence-based factors associated with poor prognosis. These were analysed against their ability to predict mortality at 1 year. 'Plan-Do-Study-Act' (PDSA) methodology was used to incorporate poor-prognosis screening into the routine assessment of patients admitted with cirrhosis, and develop a supportive care intervention. RESULTS: 73 admissions were scrutinised (79.5% male, 63% alcohol-related liver disease, median age 54). The presence of three or more poor-prognosis criteria at admission predicted 1-year mortality with sensitivity, specificity and positive predictive value of 72.2%, 83.8% and 81.3%, respectively, and was used as a trigger for implementing the supportive care intervention. Following modification from six PDSA cycles, prognostic screening was integrated into the assessment of all patients admitted with decompensated cirrhosis, with the supportive care intervention (developed simultaneously) instigated for appropriate patients. CONCLUSIONS: We describe a model of care which identifies inpatients with cirrhosis at significant risk of dying over the coming year, and describe development of a supportive care intervention, which can be offered to suitable patients in parallel to ongoing active management.
BACKGROUND AND OBJECTIVES:Patients with decompensated cirrhosis rarely receive palliative and supportive care interventions, which are routine in other life-limiting diseases. We aimed to design and evaluate a prognostic screening tool to routinely identify inpatients with decompensated cirrhosis at high risk of dying over the coming year, alongside the development of a supportive care intervention. DESIGN: Clinical notes from consecutive patients admitted as an emergency to University Hospitals Bristol with a diagnosis of cirrhosis over two distinct 90-day periods were scrutinised retrospectively for the presence or absence of five evidence-based factors associated with poor prognosis. These were analysed against their ability to predict mortality at 1 year. 'Plan-Do-Study-Act' (PDSA) methodology was used to incorporate poor-prognosis screening into the routine assessment of patients admitted with cirrhosis, and develop a supportive care intervention. RESULTS: 73 admissions were scrutinised (79.5% male, 63% alcohol-related liver disease, median age 54). The presence of three or more poor-prognosis criteria at admission predicted 1-year mortality with sensitivity, specificity and positive predictive value of 72.2%, 83.8% and 81.3%, respectively, and was used as a trigger for implementing the supportive care intervention. Following modification from six PDSA cycles, prognostic screening was integrated into the assessment of all patients admitted with decompensated cirrhosis, with the supportive care intervention (developed simultaneously) instigated for appropriate patients. CONCLUSIONS: We describe a model of care which identifies inpatients with cirrhosis at significant risk of dying over the coming year, and describe development of a supportive care intervention, which can be offered to suitable patients in parallel to ongoing active management.
Authors: Rory Francis McQuillan; Samuel Adam Silver; Ziv Harel; Adam Weizman; Alison Thomas; Chaim Bell; Glenn M Chertow; Christopher T Chan; Gihad Nesrallah Journal: Clin J Am Soc Nephrol Date: 2016-03-25 Impact factor: 8.237
Authors: Alexandra J Baumann; David S Wheeler; Marva James; Roberta Turner; Arthur Siegel; Victor J Navarro Journal: J Pain Symptom Manage Date: 2015-08-22 Impact factor: 3.612
Authors: Joseph Low; Victoria Vickerstaff; Sarah Davis; Julia Bichard; Lynda Greenslade; Katherine Hopkins; Aileen Marshall; Douglas Thorburn; Louise Jones Journal: Frontline Gastroenterol Date: 2015-07-24
Authors: Roger Williams; Richard Aspinall; Mark Bellis; Ginette Camps-Walsh; Matthew Cramp; Anil Dhawan; James Ferguson; Dan Forton; Graham Foster; Ian Gilmore; Matthew Hickman; Mark Hudson; Deirdre Kelly; Andrew Langford; Martin Lombard; Louise Longworth; Natasha Martin; Kieran Moriarty; Philip Newsome; John O'Grady; Rachel Pryke; Harry Rutter; Stephen Ryder; Nick Sheron; Tom Smith Journal: Lancet Date: 2014-11-29 Impact factor: 79.321
Authors: James G Orr; Tara Homer; Laura Ternent; Julia Newton; Calum J McNeil; Mark Hudson; David E J Jones Journal: J Hepatol Date: 2014-07-07 Impact factor: 25.083
Authors: Joseph Low; Catherine Carroll; Jo Wilson; Rachel Craig; Shree Vadera; Sara Cococcia; Douglas Thorburn; Patrick Stone; Aileen Marshall; Victoria Vickerstaff Journal: Frontline Gastroenterol Date: 2021-05-27
Authors: Jennifer Arney; Caroline Gray; Jack A Clark; Donna Smith; Annie Swank; Daniel D Matlock; Jennifer Melcher; Fasiha Kanwal; Aanand D Naik Journal: PLoS One Date: 2022-02-18 Impact factor: 3.752
Authors: Sarah Pauline Bowers; Kathleen Clare; Louise Hagerty; Kirsty McColl; Eva Smith; Alana Brown-Kerr; Asma Ahmed; Fiona Finlay; John F Dillon; Stephen Barclay Journal: BMJ Open Gastroenterol Date: 2022-03